Malik's Bold Move: 1789 Capital Invests in Controversial Drug Startup BlinkRx
In a striking development within the pharmaceutical investment landscape, 1789 Capital, under the leadership of co-founder and activist investor Vivek Malik, has announced a significant investment in BlinkRx, a drug startup that is rapidly making waves for its unique business model and strong ideological stance. This partnership is not just about financial backing; it also exemplifies Malik's commitment to moving against the prevailing “woke” culture that he believes has stifled innovation and growth in the industry.
Continue readingCFOs Embrace Venture Capital Strategies to Drive Corporate Growth
In a notable shift within the corporate landscape, Chief Financial Officers (CFOs) from major companies such as Aflac and General Mills are increasingly adopting venture capital strategies as a means of fostering growth and innovation. This trend reflects a broader recognition among corporate leaders that traditional methods of financing and investment are often insufficient in today's fast-paced and competitive market environment.
Continue readingOlivia Wilde Innovates in Investment: Co-Founding Proximity Ventures
In a surprising move that blends her passion for storytelling with a keen eye for investment, actress and director Olivia Wilde has entered the venture capital arena. She has quietly co-founded a new venture capital firm called Proximity Ventures, aimed at supporting and amplifying startups that prioritize innovation, creativity, and social impact. This expansion into finance signals a significant shift in Wilde's career trajectory, showcasing her multi-faceted talents beyond her considerable accomplishments in film and television.
Continue reading